Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools. | Curr Issues Mol Biol | 2022 | 36354663 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. | Clin Transl Med | 2022 | 36333281 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Genome-wide by Environment Interaction Study of Stressful Life Events and Hospital-Treated Depression in the iPSYCH2012 Sample. | Biol Psychiatry Glob Open Sci | 2022 | 36324662 | PubTator, text mining | PubMed |
| Neutrophils in pancreatic cancer: Potential therapeutic targets. | Front Oncol | 2022 | 36324574 | PubTator, text mining | PubMed |
| The importance of being CAFs (in cancer resistance to targeted therapies). | J Exp Clin Cancer Res | 2022 | 36324182 | PubTator, text mining | PubMed |
| First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors. | J Immunother Cancer | 2022 | 36316061 | PubTator, text mining | PubMed |
| Mechanisms of venetoclax resistance and solutions. | Front Oncol | 2022 | 36313732 | PubTator, text mining | PubMed |
| Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition. | Front Oncol | 2022 | 36313710 | PubTator, text mining | PubMed |
| Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria. | Front Cardiovasc Med | 2022 | 36312244 | PubTator, text mining | PubMed |
| Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis. | J Exp Clin Cancer Res | 2022 | 36307871 | PubTator, text mining | PubMed |
| Exploratory analysis of interleukin-38 in hospitalized COVID-19 patients. | Immun Inflamm Dis | 2022 | 36301025 | PubTator, text mining | PubMed |
| Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers. | Front Oncol | 2022 | 36300092 | PubTator, text mining | PubMed |
| Characterization of fatty acid metabolism-related lncRNAs in lung adenocarcinoma identifying potential novel prognostic targets. | Front Genet | 2022 | 36299578 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. | Pharmaceuticals (Basel) | 2022 | 36297381 | PubTator, text mining | PubMed |
| Vitamin K Contribution to DNA Damage-Advantage or Disadvantage? A Human Health Response. | Nutrients | 2022 | 36296903 | PubTator, text mining | PubMed |
| Genetic Factors for Coronary Heart Disease and Their Mechanisms: A Meta-Analysis and Comprehensive Review of Common Variants from Genome-Wide Association Studies. | Diagnostics (Basel) | 2022 | 36292250 | PubTator, text mining | PubMed |
| Treatment of Refractory Metastatic Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36291789 | PubTator, text mining | PubMed |
| Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients. | Biomolecules | 2022 | 36291697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=39